For comparison of antifungal drug resistance between Candida albicans
and NAC, Chi-square test was used, and for comparison of drug resistance among different species of Candida, Kruskal-Wallis ANOVA test was applied.
Keywords: Candida albicans
, Non-albicans (NAC), Antifungal sensitivity test, CHROMagar Candida.
is the leading yeast involved in fungal infections in the world, though other species start to detach, this species still remains isolated from samples of urine, blood, secretions, among other biological samples (Quindos, 2014).
NDV-3A is being developed as an immunotherapy and as a preventative vaccine for infections caused by several species of the fungus Candida, including Candida albicans
, and the bacterium Staphylococcus aureus, including MRSA.
Purpose: We tested the antifungal activity of N,N-phenyl-1,2,3,4-thiatriazole-5-yl-2,4-b-resorcyl-carbothioamide (PTR) ; n-3-(1,2,4-dithiazole-5-thione)-[beta]-resorcylcarbothioamide (DTRTA) ; N,N-phenyl-1,2,3,4-thiatriazol-5-yl-2,4-b-resorcyl-carbothioamide (PHARA) against Candida albicans
strains in vitro.
It has been suggested that in patients wearing dentures, particularly patients with poor oral hygiene, Candida albicans
can affix to the resin, form denture plaque, and become for lead to diseases in the entire body, such as aspiration pneumonitis [1-30].
Yeast infections are most commonly caused by the fungus Candida albicans
The present study was designed to determine the antifungal activity of Aloe vera and Cymbopogon citratus extracts against Candida albicans
and to compare their antifungal effect with that of terbinafine and with each other.
Among them, Candida albicans
is the predominant species occurring in human oral cavity (3).
Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans
October 26, 2016 -- Researchers here and in Spain have partnered to describe a biological mechanism that generates cells which are better equipped to fight off serious infections caused by the Candida albicans
4 shows out of 53 isolates, Candida albicans
which showed sensitivity to Voriconazole were 92%, Flucytosine were 92% Amphotericin B were 89%, Fluconazole were 81%, Micafungin were 78%, Caspofungin were 75%.